Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAscent Resources Regulatory News (AST)

Share Price Information for Ascent Resources (AST)

Share Price is delayed by 15 minutes
Get Live Data
0.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.10 (22.222%)
Market Cap: £4.16m
AST Live PriceLast checked at - London Stock Exchange

Intraday Ascent Resources Share Chart

Board Changes

30 Jul 2025 07:00

RNS Number : 0844T
Ascent Resources PLC
30 July 2025
 

 

30 July 2025

Ascent Resources plc

("Ascent" or the "Company")

 

Ascent Resources Plc (LON: AST), the onshore US focused oil & gas company, is pleased to announce the appointment of Mr Jean-Michel Doublet as Independent Non-Executive Chairman and Mr David Patterson as an Executive Director with immediate effect.

Jean-Michel was initially appointed to the Board on 21 November 2023 as an independent Non-Executive Director and since 22 May 2025 has held the position of Interim-Chairman.

The Company is also pleased to announce that, further to the announcements on 22 May 2025 and 9 July 2025, David Patterson, CEO of the Company, has been appointed as an Executive Director to the Board with immediate effect, following the completion of standard regulatory checks.

David is an experienced oil and gas explorer and geologist with over 43 years oil and gas experience onshore US, including several years in Utah and Colorado, most notably as VP Geology for Rose Petroleum Plc (now called Zephyr Energy Plc) where he led the evaluation of over 250,000 acres of leases in Utah. David held previous roles, including VP and manager of Exploration, VP of Geology, Supervisor of Reserves and Senior Geological Engineer, through his career and is based in Colorado.

The following information is disclosed in accordance with Rule 17 and paragraph (g) of Schedule 2 of the AIM Rules for Companies in connection with the appointment of David Patterson, aged 66, to the Board of the Company.

Current Directorships

Past Directorships

Strike Exploration LLC

Navarro Energy

There are no other matters under paragraph (g) of Schedule 2 of the AIM Rules to be disclosed.

Jean-Michel Doublet, Chairman commented:

"We are delighted that David is joining the Board, as CEO and Executive Director. I, in my new role as Chairman of the Company, together with the rest of the Board welcome David and look forward to working with him to deliver the Company's ambitious strategy in the US."

Enquiries

Ascent Resources plc

Jean-Michel Doublet

info3@ascentresources.co.uk

 

Zeus, Nominated Adviser & Broker

James Joyce / James Bavister

0203 829 5000

Novum Securities, Joint Broker

Jon Belliss / Colin Rowbury

0207 399 9400

 

Fortified Securities, Joint-Broker

Guy Wheatley

0203 411 7773

Shard Capital Partners LLP, Joint-Broker

Damon Heath

0207 186 9952

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOASEFESUEISEDW
Date   Source Headline
11th Feb 20217:00 amRNSStrategy Update & New Funding
9th Feb 20216:25 pmRNSHolding(s) in Company
9th Feb 202111:07 amRNSFurther Slovenian Operations Update
5th Feb 20215:29 pmRNSExercise of warrants
5th Feb 20217:00 amRNSSlovenia Update
4th Feb 20214:41 pmRNSSecond Price Monitoring Extn
4th Feb 20214:39 pmRNSExercise of warrants and repayment of debt
4th Feb 20214:36 pmRNSPrice Monitoring Extension
3rd Feb 20214:40 pmRNSSecond Price Monitoring Extn
3rd Feb 20214:35 pmRNSPrice Monitoring Extension
3rd Feb 20212:05 pmRNSSecond Price Monitoring Extn
3rd Feb 20212:00 pmRNSPrice Monitoring Extension
2nd Feb 20214:41 pmRNSSecond Price Monitoring Extn
2nd Feb 20214:35 pmRNSPrice Monitoring Extension
2nd Feb 20212:06 pmRNSSecond Price Monitoring Extn
2nd Feb 20212:00 pmRNSPrice Monitoring Extension
29th Jan 20214:39 pmRNSTotal Voting Rights
27th Jan 20216:26 pmRNSHolding(s) in Company
25th Jan 20215:44 pmRNSHolding(s) in Company
22nd Jan 20215:48 pmRNSHolding(s) in Company
13th Jan 20215:28 pmRNSHolding(s) in Company
11th Jan 20217:00 amRNSExercise of warrants and loan repayment
6th Jan 20212:17 pmRNSIssue of Consultancy Shares
31st Dec 202012:15 pmRNSTotal Voting Rights
14th Dec 202011:50 amRNSDirector/PDMR Shareholding
11th Dec 20208:00 amRNSDirector/PDMR Shareholding
10th Dec 20204:05 pmRNSHolding(s) in Company
9th Dec 20207:00 amRNSHolding(s) in Company
7th Dec 20208:52 amRNSHolding(s) in Company
4th Dec 20204:40 pmRNSSecond Price Monitoring Extn
4th Dec 20204:35 pmRNSPrice Monitoring Extension
4th Dec 20207:00 amRNSHolding(s) in Company
1st Dec 20207:00 amRNSNew Funding
27th Nov 20207:53 amRNSHolding(s) in Company
18th Nov 20205:49 pmRNSRevised block listing application
16th Nov 202012:23 pmRNSBlock listing application
11th Nov 20204:49 pmRNSHolding(s) in Company
11th Nov 20203:27 pmRNSHolding(s) in Company
11th Nov 20201:04 pmRNSHolding(s) in Company
9th Nov 20208:37 amRNSHolding(s) in Company
5th Nov 20204:44 pmRNSIssue of Consultancy Shares
2nd Nov 20207:00 amRNSHolding(s) in Company
2nd Nov 20207:00 amRNSCuba Update: MOU Extension
30th Oct 20204:40 pmRNSSecond Price Monitoring Extn
30th Oct 20204:35 pmRNSPrice Monitoring Extension
30th Oct 20202:05 pmRNSSecond Price Monitoring Extn
30th Oct 20202:00 pmRNSPrice Monitoring Extension
30th Oct 202012:34 pmRNSExercise of warrants and debt update
30th Oct 202011:58 amRNSHolding(s) in Company
30th Oct 202011:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.